Mechanical Ventilation in Brain-injured Patients (BI-VILI)

February 19, 2015 updated by: Nantes University Hospital

Duration of Mechanical Ventilation and Mortality Among Brain-injured Patients - a Before-after Evaluation of a Quality Improvement Project

Protective ventilation (association of a tidal volume < 8 ml/kg with a positive end expiratory pressure) is poorly used in severe brain-injured patients. Moreover, a systematic approach to extubation may decrease the rate of extubation failure and enhance outcomes of brain-injured patients.

We hypothesized that medical education and implementation of an evidence-base care bundle associating protective ventilation and systemic approach to extubation can reduce the duration of mechanical ventilation in brain-injured patients.

Study Overview

Detailed Description

A before/after study design will be used. The before period (control phase) will consisted of all consecutive patients with severe brain-injury who were admitted to the participating ICUs.

During the interphase, all physicians, residents, physiotherapists and nurses will receive a formal training for the processes and procedures related to the 2 point bundle: protective ventilation and systematic approach to extubation (according to recommendation for the use of tidal volume < 7 ml/kg and of a positive expiratory pressure = 6 to 8 cmH20 (centimeter of water) and extubation as soon as ventilatory weaning is associated with a glasgow coma scale equal or above 10 and cought).

The after period consisted of all consecutive severe brain-injured patients admitted to the participating ICUs after the formal training.

Study Type

Observational

Enrollment (Actual)

560

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France
        • Angers University Hospital
      • Beaujon, France
        • Beaujon hospital
      • Brest, France
        • Brest university hospital
      • Caen, France
        • CAEN university Hospital
      • Clermont-Ferrand, France
        • Clermont-Ferrand University Hospital
      • Créteil, France
        • Henri Mondor University Hospital
      • Grenoble, France
        • Grenoble University Hospital
      • Le Kremlin Bicêtre, France
        • Bicêtre University Hospital
      • Marseille, France
        • Marseille University Hospital
      • Montpellier, France
        • Montpellier University Hospital
      • Nantes, France
        • Nantes University Hospital
      • Nice, France
        • Nice university hospital
      • Nime, France
        • Nîmes University Hospital
      • Paris, France
        • Georges Pompidou European Hospital
      • Poitiers, France
        • Poitiers university hospital
      • Rennes, France
        • Rennes university hospital
      • Rouen, France
        • Rouen university hospital
      • Saint Herblain, France
        • Nantes University Hospital
      • Toulouse, France
        • Toulouse University Hospital - Purpan
      • Toulouse, France
        • Toulouse University Hospital - Rangueil
      • Tours, France
        • Tours Univeristy Hospital - Neurosurgery ICU
      • Tours, France
        • Tours University Hospital - Neurotrauma ICU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Structural coma.

Description

Inclusion Criteria:

  • Adult patients (traumatic brain-injured, subarachnoid hemorrhage, stroke or other)
  • Brain injury (Glasgow Coma Scale ≤ 12 associated with at least one anomaly related to an acute process on head tomographic tomodensitometry
  • mechanical ventilation for more than 24 hours

Exclusion Criteria:

  • early decision to withdraw care (taken in the first 24 hours in ICU),
  • death in the first 24 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control phase (before)
Process of care and outcomes before the educational program
Training phase (after)

Process of care and outcomes after the educational program which recommends:

  • the use of tidal volume < 7 ml/kg and of a positive expiratory pressure = 6 to 8 cmH20 (centimeter of water)
  • extubation as soon as ventilatory weaning is associated with a glasgow coma scale equal or above 10 and cough
  • the use of tidal volume < 7 ml/kg and of a positive expiratory pressure = 6 to 8 cmH20 (centimeter of water)
  • extubation as soon as ventilatory weaning is associated with a glasgow coma scale equal or above 10 and cough

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mechanical ventilatory free days
Time Frame: Day-90
The number of ventilator-free days was defined as the number of days from day 1 to day 90 on which a patient breaths spontaneously and is alive
Day-90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of mechanical ventilation
Time Frame: 90 days
90 days
Mortality
Time Frame: day-90
day-90
In-ICU mortality
Time Frame: 90 days
90 days
ICU free days at day 90
Time Frame: day 90
The number of ICU free days was defined as the number of days from day 1 to on which a patient is alive and not hospitalized in ICU
day 90
Acute respiratory distress syndrome / acute lung injury
Time Frame: day-90
day-90
Hospital acquired pneumonia
Time Frame: day-90
day-90
Blood gaz
Time Frame: day-5
PaO2 (arterial pressure of oxygen) and PaCO2 (arterial pressure of dioxide of carbon)
day-5
Intracranial pressure
Time Frame: day-5
day-5
Glasgow outcome scale
Time Frame: day-90
day-90
Extubation failure
Time Frame: day-90
day-90
Ventilatory setting
Time Frame: day-5
Tidal volume and Positive end expiratory pressure
day-5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karim Asehnoune, MD, PhD, Nantes University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

June 18, 2013

First Submitted That Met QC Criteria

June 20, 2013

First Posted (Estimate)

June 25, 2013

Study Record Updates

Last Update Posted (Estimate)

February 23, 2015

Last Update Submitted That Met QC Criteria

February 19, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Pass recommendations on ventilation factors and extubation

3
Subscribe